• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从狗及其主人身上同时测序的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎亚变体的家庭聚集情况。

Household clusters of SARS-CoV-2 Omicron subvariants contemporaneously sequenced from dogs and their owners.

作者信息

Ferreira Francisco C, Auckland Lisa D, Busselman Rachel E, Davila Edward, Tang Wendy, Lim Ailam, Sarbo Nathan, Yaglom Hayley D, Centner Heather, Mead Heather L, Tao Ying, Castro Juan, Li Yan, Zhang Jing, Wang Haibin, Malapati Lakshmi, Cook Peter, Retchless Adam, Tong Suxiang, Zecca Italo B, Ghai Ria R, Barton Behravesh Casey, Fischer Rebecca S B, Hamer Gabriel L, Hamer Sarah A

机构信息

Department of Entomology, Texas A&M University, College Station, Texas, USA.

Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, USA.

出版信息

mSphere. 2025 Jul 2:e0007425. doi: 10.1128/msphere.00074-25.

DOI:10.1128/msphere.00074-25
PMID:40600703
Abstract

Monitoring the zoonotic potential of emerging SARS-CoV-2 variants in animals is a critical tool to protect public health. We conducted a longitudinal study in 47 households reporting people with COVID-19 in Texas from January to July 2022, during the first Omicron wave. We evaluated 105 people and 100 of their companion animals for SARS-CoV-2 infection at three sequential sampling events, starting 0-5 days after the first reported diagnosis of COVID-19 in the house. SARS-CoV-2 RNA was detected in 68% of people from 43 households; 95.5% of people had antibodies to SARS-CoV-2. Dogs were the only animal species positive by RT-qPCR (5.4%; 3/55), and their viral loads were consistently lower compared with those from household members. Additionally, infected dogs did not yield infectious virus. Clusters of Omicron BA.1.1, BA.2.3.4, and BA.5.1.1 in people, dogs, and a dog food bowl confirmed human-to-dog transmission within households, with no evidence of onward transmission from the infected dogs. Eleven dogs ( = 55) and two cats ( = 26) had neutralizing antibodies against SARS-CoV-2. Overall, infection was not associated with clinical signs in pets; only two animals that tested negative for SARS-CoV-2 were reported to be sick. Nearly one-third (30.2%) of households with active COVID-19 had pets exposed to SARS-CoV-2, similar to our pre-Omicron studies; however, the incidence of infection in cats was lower compared with pre-Omicron. These differences suggest that the zoonotic transmission dynamics in households may differ based on variants.IMPORTANCESARS-CoV-2 infects a broad diversity of mammals, with companion dogs and cats at risk of infection via close contact with infectious owners. Longitudinal studies sampling pets and their owners over time are essential to understanding within-household SARS-CoV-2 transmission dynamics. Our repeated sampling in households with people reporting COVID-19 found that 68% of the people in 43 households had active SARS-CoV-2 infection during at least one of the three sampling events. Although none of the 27 cats were positive, 3/55 dogs had active infections. Household clusters of three different Omicron subvariants were involved in these human-to-dog transmission events, and our data suggest reduced infection in pets during Omicron transmission compared with pre-Omicron waves. Protecting pets from SARS-CoV-2 infection remains important, as viral evolution can be accompanied by changes in the infectiousness of different hosts.

摘要

监测新出现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变种在动物中的人畜共患病潜力是保护公众健康的关键工具。在2022年1月至7月奥密克戎毒株第一波流行期间,我们对得克萨斯州47户报告有新冠病毒病患者的家庭进行了一项纵向研究。我们在三个连续的采样点对105人及其100只伴侣动物进行了SARS-CoV-2感染评估,从家中首次报告新冠病毒病诊断后的0至5天开始。在来自43户家庭的68%的人中检测到了SARS-CoV-2 RNA;95.5%的人具有抗SARS-CoV-2抗体。狗是唯一通过逆转录定量聚合酶链反应(RT-qPCR)检测呈阳性的动物物种(5.4%;55只中有3只),与家庭成员相比,它们的病毒载量一直较低。此外,受感染的狗没有产生传染性病毒。在人、狗和一个狗粮碗中发现的奥密克戎BA.1.1、BA.2.3.4和BA.5.1.1毒株集群证实了家庭内的人传人狗传播,没有证据表明受感染的狗会发生进一步传播。11只狗(共55只)和2只猫(共26只)具有抗SARS-CoV-2的中和抗体。总体而言,感染与宠物的临床症状无关;据报告只有两只SARS-CoV-2检测呈阴性的动物生病。近三分之一(30.2%)有活跃新冠病毒病病例的家庭中,宠物接触过SARS-CoV-2,这与我们在奥密克戎毒株出现之前的研究结果相似;然而,与奥密克戎毒株出现之前相比,猫的感染率较低。这些差异表明,家庭中的人畜共患病传播动态可能因变种而异。重要性SARS-CoV-2可感染多种哺乳动物,伴侣犬和猫有通过与感染性主人密切接触而感染的风险。随着时间推移对宠物及其主人进行采样的纵向研究对于了解家庭内SARS-CoV-2传播动态至关重要。我们在报告有新冠病毒病患者的家庭中进行的重复采样发现,在43户家庭中,68%的人在三次采样事件中的至少一次期间有活跃的SARS-CoV-2感染。虽然27只猫均未呈阳性,但55只狗中有3只发生了活跃感染。三种不同奥密克戎亚变种的家庭集群参与了这些人传人狗的传播事件,我们的数据表明,与奥密克戎毒株出现之前的波次相比,奥密克戎毒株传播期间宠物感染减少。保护宠物免受SARS-CoV-2感染仍然很重要,因为病毒进化可能伴随着不同宿主传染性的变化。

相似文献

1
Household clusters of SARS-CoV-2 Omicron subvariants contemporaneously sequenced from dogs and their owners.从狗及其主人身上同时测序的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎亚变体的家庭聚集情况。
mSphere. 2025 Jul 2:e0007425. doi: 10.1128/msphere.00074-25.
2
Evidence of SARS-CoV-2 Exposure in Cats and Dogs From Households in Romania and Long-Term Specific Seroconversion in Cats.罗马尼亚家庭猫狗感染严重急性呼吸综合征冠状病毒2的证据及猫的长期特异性血清转化
Vet Med Sci. 2025 May;11(3):e70358. doi: 10.1002/vms3.70358.
3
Surveillance of SARS-CoV-2 in Pets of Harris County, Texas, Revealed More Common Pet Infections in Households With Human COVID-19 Cases.对得克萨斯州哈里斯县宠物身上的新型冠状病毒(SARS-CoV-2)监测显示,在有人类感染新冠病毒(COVID-19)病例的家庭中,宠物感染更为常见。
Vet Med Sci. 2025 Mar;11(2):e70218. doi: 10.1002/vms3.70218.
4
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
5
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
8
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.针对 COVID-19 的一种改良信使核糖核酸-脂质纳米颗粒候选疫苗的安全性和免疫原性:一项 1 期、剂量递增研究的结果。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2408863. doi: 10.1080/21645515.2024.2408863. Epub 2024 Oct 18.
9
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
10
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.

本文引用的文献

1
Dogs and Cats Are Less Susceptible to the Omicron Variant of Concern of SARS-CoV-2: A Field Study in Germany, 2021/2022.犬猫对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关切的奥密克戎变种易感性较低:2021/2022年德国的一项实地研究
Transbound Emerg Dis. 2023 Oct 12;2023:1868732. doi: 10.1155/2023/1868732. eCollection 2023.
2
Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic.遗传追踪新冠疫情中心的市场野生动物和病毒。
Cell. 2024 Sep 19;187(19):5468-5482.e11. doi: 10.1016/j.cell.2024.08.010.
3
The comparison of pathogenicity among SARS-CoV-2 variants in domestic cats.
新冠病毒变异株在国内猫群中的致病性比较。
Sci Rep. 2024 Sep 18;14(1):21815. doi: 10.1038/s41598-024-71791-8.
4
Validating the inactivation of viral pathogens with a focus on SARS-CoV-2 to safely transfer samples from high-containment laboratories.验证病毒病原体的灭活效果,重点关注 SARS-CoV-2,以确保安全地从高防护实验室转移样本。
Front Cell Infect Microbiol. 2024 Mar 6;14:1292467. doi: 10.3389/fcimb.2024.1292467. eCollection 2024.
5
Prevalence of persistent SARS-CoV-2 in a large community surveillance study.大型社区监测研究中 SARS-CoV-2 的持续流行率。
Nature. 2024 Feb;626(8001):1094-1101. doi: 10.1038/s41586-024-07029-4. Epub 2024 Feb 21.
6
Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2.斑块减少中和试验(PRNT)在评估对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的体液免疫反应中的准确性
Diseases. 2024 Jan 18;12(1):29. doi: 10.3390/diseases12010029.
7
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study.SARS-CoV-2 人体挑战后病毒向空气中和环境中的排放:一项 1 期、开放标签、首次人体研究。
Lancet Microbe. 2023 Aug;4(8):e579-e590. doi: 10.1016/S2666-5247(23)00101-5. Epub 2023 Jun 9.
8
Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study.SARS-CoV-2 家庭传播的风险因素和媒介:一项前瞻性、纵向队列研究。
Lancet Microbe. 2023 Jun;4(6):e397-e408. doi: 10.1016/S2666-5247(23)00069-1. Epub 2023 Apr 6.
9
Zooanthroponotic transmission of SARS-CoV-2 and host-specific viral mutations revealed by genome-wide phylogenetic analysis.全基因组系统进化分析揭示 SARS-CoV-2 的人畜共患传播和宿主特异性病毒突变。
Elife. 2023 Apr 4;12:e83685. doi: 10.7554/eLife.83685.
10
Experimental Infection and Transmission of SARS-CoV-2 Delta and Omicron Variants among Beagle Dogs.实验感染贝格尔犬中的 SARS-CoV-2 德尔塔和奥密克戎变异株及其传播。
Emerg Infect Dis. 2023 Apr;29(4):782-785. doi: 10.3201/eid2904.221727. Epub 2023 Feb 27.